Nichols & Pratt Advisers LLP MA maintained its position in Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,409 shares of the conglomerate’s stock at the end of the second quarter. Nichols & Pratt Advisers LLP MA’s holdings in Danaher Corporation were worth $962,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. Waldron LP purchased a new stake in shares of Danaher Corporation during the 1st quarter valued at $320,000. Empire Life Investments Inc. increased its holdings in shares of Danaher Corporation by 2.3% during the 1st quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock worth $6,662,000 after buying an additional 1,764 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Danaher Corporation by 6.9% during the 1st quarter. Advisors Asset Management Inc. now owns 81,481 shares of the conglomerate’s stock worth $6,969,000 after buying an additional 5,271 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Danaher Corporation by 108.5% during the 1st quarter. American Century Companies Inc. now owns 1,928,414 shares of the conglomerate’s stock worth $164,937,000 after buying an additional 1,003,306 shares during the last quarter. Finally, FTB Advisors Inc. increased its holdings in shares of Danaher Corporation by 93.0% during the 1st quarter. FTB Advisors Inc. now owns 6,036 shares of the conglomerate’s stock worth $511,000 after buying an additional 2,908 shares during the last quarter. 75.68% of the stock is currently owned by institutional investors.

In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the transaction, the director now owns 42,151 shares in the company, valued at $3,499,797.53. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider William King sold 43,688 shares of the stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares in the company, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 71,496 shares of company stock valued at $5,916,223. Corporate insiders own 12.20% of the company’s stock.

Shares of Danaher Corporation (NYSE:DHR) opened at 86.52 on Wednesday. The company’s 50-day moving average is $84.54 and its 200-day moving average is $84.14. The firm has a market capitalization of $60.10 billion, a price-to-earnings ratio of 27.62 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.62.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.90 EPS. On average, equities analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.65%. Danaher Corporation’s dividend payout ratio (DPR) is currently 17.83%.

TRADEMARK VIOLATION NOTICE: “Nichols & Pratt Advisers LLP MA Continues to Hold Stake in Danaher Corporation (DHR)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/10/04/nichols-pratt-advisers-llp-ma-continues-to-hold-stake-in-danaher-corporation-dhr.html.

A number of equities research analysts have issued reports on the company. Zacks Investment Research downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Monday, June 19th. Deutsche Bank AG restated a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research note on Wednesday, June 21st. Wells Fargo & Company initiated coverage on Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective on the stock. BidaskClub downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $91.98.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.